Arch Venture Partners

Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture…

Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs

I’m not a branding expert. I can recognize, however, that one sets certain expectations by naming a product “Happy Ring.” Mental health is a delicate space, and not something to…

Tinder founder’s latest play is a ring for quantifying mental health

Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and…

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million…

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life sciences investor ARCH…

ARCH Venture Partners raises $1.46 billion across two funds for biotech investing

Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for…

Aspen Neuroscience raises $70M for its experimental Parkinson’s Disease treatment

Mindstrong Health is tackling one of the most difficult challenges in healthcare: Severe mental illness, commonly referred to as SMI in the healthcare industry. The startup, founded in 2013 by…

Mindstrong Health hires leadership team with all-star tech product experience

There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting…

Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders